BELGRADE, Serbia, March 24, 2025 /PRNewswire/ -- From March 17th to 21st, the China Council for the Promotion of International…
February 18, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) --…
Opens its first store in India at HQ27 Gurugram in partnership with Vita NovaAims to expand presence by establishing 5…
FAIRFIELD, N.J., Jan. 16, 2025 /PRNewswire/ -- Keypoint Intelligence is pleased to announce that Charles Lissenburg has been appointed as…
Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability…
Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability…
CAESAREA, Israel, Jan. 8, 2025 /PRNewswire/ -- Alma Lasers, a Sisram Medical company and a global leader in energy-based medical and…
CAESAREA, Israel, Jan. 8, 2025 /PRNewswire/ -- Alma Lasers, a Sisram Medical company and a global leader in energy-based medical and…
![Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma](https://i3.wp.com/mma.prnewswire.com/media/597589/4648918/Norgine_Logo.jpg?p=thumbnail&w=144&resize=144,109&ssl=1){kind=logo}
Back to media releasesNext media release LONDON, Jan. 7, 2025 /PRNewswire/ -- Norgine today announced that it completed its marketing…
HEIDELBERG, Germany, Dec. 25, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) has launched a new research initiative focused on Klotho,…
